Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 05 Jul 2017
ABSCH-IRCC-IN-237723-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/889
Application in Form-III for seeking approval for the invention " A Method of isolation of Pharmacologically potent oil from edible wild bamboo seeds (Bambusa bambos Druce)” for obtaining IP Rights in India
24 Oct 2016
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Person:Dr Venkatesh Palaniyappan Palaniyappan12/66 Ramnathapuram,VeeraganurSalem, Tamil Nadu
636116, IndiaPhone: +919704572458,Fax:Email: venkat7pharma@rediffmail.com,Website:
Confidential information
Yes
1. The user shall notify the NBA on the grant of IPR within 30 days from the grant.
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes.
3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention “A Method of Isolation of Pharmacologically potent oil from edible wild bamboo seeds (Bambusa bambos Druce)” in India
Biological resources : Bamboo – Bambusa bambos
Confidential information
- Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee.
2. In case the user assigns or transfer the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-237723-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
05 Jul 2017 10:17 on 05 Jul 2017 10:17
|
